Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Neuroprotective agents are medications that can alter the course of metabolic events after the onset of ischemia and therefore have the potential to reduce stroke damage.
The report details the trend, potential and market size of Neuroprotective Agents market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neuroprotective Agentsmarket, defines the market attractiveness level of Neuroprotective Agents market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neuroprotective Agents industry, describes the types of Neuroprotective Agents market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neuroprotective Agents market and the development prospects and opportunities of Neuroprotective Agents industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neuroprotective Agents market in Chapter 13.
By Player:
Neuren Pharmaceuticals
Ceregene
Allon Therapeutics
Genervon Biopharmaceuticals
NeuroVive Pharmaceutical
By Type:
Cerebrovascular Diseases
Neurodegenerative Disorders
Ophthalmic Diseases
Traumatic CNS Injuries
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neuroprotective Agents Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neuroprotective Agents Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neuroprotective Agents Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neuroprotective Agents Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neuroprotective Agents Market Analysis and Outlook to 2022
-
7.1 Global Neuroprotective Agents Consumption (2017-2022)
-
7.2 United States Neuroprotective Agents Consumption (2017-2022)
-
7.3 Europe Neuroprotective Agents Consumption (2017-2022)
-
7.4 China Neuroprotective Agents Consumption (2017-2022)
-
7.5 Japan Neuroprotective Agents Consumption (2017-2022)
-
7.6 India Neuroprotective Agents Consumption (2017-2022)
-
7.7 South Korea Neuroprotective Agents Consumption (2017-2022)
8 Region and Country-wise Neuroprotective Agents Market Analysis and Outlook to 2028
-
8.1 Global Neuroprotective Agents Consumption Forecast (2022-2028)
-
8.2 United States Neuroprotective Agents Consumption Forecast (2022-2028)
-
8.3 Europe Neuroprotective Agents Consumption Forecast (2022-2028)
-
8.4 China Neuroprotective Agents Consumption Forecast (2022-2028)
-
8.5 Japan Neuroprotective Agents Consumption Forecast (2022-2028)
-
8.6 India Neuroprotective Agents Consumption Forecast (2022-2028)
-
8.7 South Korea Neuroprotective Agents Consumption Forecast (2022-2028)
9 Global Neuroprotective Agents Market Outlook by Types and Applications to 2022
-
9.1 Global Neuroprotective Agents Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Cerebrovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Neurodegenerative Disorders Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Ophthalmic Diseases Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Traumatic CNS Injuries Consumption and Growth Rate (2017-2022)
-
9.2 Global Neuroprotective Agents Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Neuroprotective Agents Market Outlook by Types and Applications to 2028
-
10.1 Global Neuroprotective Agents Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Cerebrovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Neurodegenerative Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Ophthalmic Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Traumatic CNS Injuries Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neuroprotective Agents Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Neuroprotective Agents Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neuroprotective Agents Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neuroprotective Agents Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neuroprotective Agents Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neuroprotective Agents Market Competitive Analysis
-
14.1 Neuren Pharmaceuticals
-
14.1.1 Neuren Pharmaceuticals Company Details
-
14.1.2 Neuren Pharmaceuticals Neuroprotective Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Neuren Pharmaceuticals Neuroprotective Agents Product and Service
-
14.2 Ceregene
-
14.2.1 Ceregene Company Details
-
14.2.2 Ceregene Neuroprotective Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Ceregene Neuroprotective Agents Product and Service
-
14.3 Allon Therapeutics
-
14.3.1 Allon Therapeutics Company Details
-
14.3.2 Allon Therapeutics Neuroprotective Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Allon Therapeutics Neuroprotective Agents Product and Service
-
14.4 Genervon Biopharmaceuticals
-
14.4.1 Genervon Biopharmaceuticals Company Details
-
14.4.2 Genervon Biopharmaceuticals Neuroprotective Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Genervon Biopharmaceuticals Neuroprotective Agents Product and Service
-
14.5 NeuroVive Pharmaceutical
-
14.5.1 NeuroVive Pharmaceutical Company Details
-
14.5.2 NeuroVive Pharmaceutical Neuroprotective Agents Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 NeuroVive Pharmaceutical Neuroprotective Agents Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neuroprotective Agents
-
Figure Neuroprotective Agents Picture
-
Table Global Neuroprotective Agents Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuroprotective Agents Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuroprotective Agents Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neuroprotective Agents Consumption by Country (2017-2022)
-
Figure United States Neuroprotective Agents Consumption and Growth Rate (2017-2022)
-
Table Europe Neuroprotective Agents Consumption and Growth Rate (2017-2022)
-
Figure China Neuroprotective Agents Consumption and Growth Rate (2017-2022)
-
Figure Japan Neuroprotective Agents Consumption and Growth Rate (2017-2022)
-
Figure India Neuroprotective Agents Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neuroprotective Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Neuroprotective Agents Consumption Forecast by Country (2022-2028)
-
Figure United States Neuroprotective Agents Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neuroprotective Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neuroprotective Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neuroprotective Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neuroprotective Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neuroprotective Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cerebrovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Neurodegenerative Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Ophthalmic Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Traumatic CNS Injuries Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Cerebrovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurodegenerative Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ophthalmic Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Traumatic CNS Injuries Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neuroprotective Agents Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neuroprotective Agents Export by Region (Top 5 Countries) (2017-2028)
-
Table Neuren Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Neuren Pharmaceuticals Neuroprotective Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neuren Pharmaceuticals Neuroprotective Agents Product and Service
-
Table Ceregene (Foundation Year, Company Profile and etc.)
-
Table Ceregene Neuroprotective Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ceregene Neuroprotective Agents Product and Service
-
Table Allon Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Allon Therapeutics Neuroprotective Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allon Therapeutics Neuroprotective Agents Product and Service
-
Table Genervon Biopharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Genervon Biopharmaceuticals Neuroprotective Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genervon Biopharmaceuticals Neuroprotective Agents Product and Service
-
Table NeuroVive Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table NeuroVive Pharmaceutical Neuroprotective Agents Sales, Price, Value and Gross Profit (2017-2022)
-
Table NeuroVive Pharmaceutical Neuroprotective Agents Product and Service
-
